
[Cancer Research 58, 5075-5078, November 15, 1998]
© 1998 American Association for Cancer Research
Functional Interactions of p53 with Poly(ADP-ribose) Polymerase (PARP) during Apoptosis following DNA Damage: Covalent Poly(ADP-ribosyl)ation of p53 by Exogenous PARP and Noncovalent Binding of p53 to the Mr 85,000 Proteolytic Fragment1
Sunitha R. Kumari,
Hilda Mendoza-Alvarez and
Rafael Alvarez-Gonzalez2
Department of Molecular Biology and Immunology, University of North Texas Health Science Center, Fort Worth, Texas 76107
We have examined the domain-specific interactions between p53 and poly(ADP-ribose)polymerase (PARP) (E.C. 2.4.2.30) in apoptotic HeLa cells. Apoptosis was induced by exposing cells to 50 µM N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) for increasing lengths of time and was confirmed by: (a) oligonucleosomal fragmentation of chromatin; (b) increase in p53 levels; and (c) degradation of PARP into the characteristic Mr 85,000 (COOH-terminal catalytic domain) and Mr 29,000 (DNA-binding domain) peptide fragments. We also immunodetected p53 in immunoprecipitates obtained with a PARP-specific antibody. However, intact PARP coimmunoprecipitated with a p53-specific antibody during the initial 30 min of MNNG treatment. After 60 min, only the COOH-terminal fragment coimmunoprecipitated with p53, indicating that PARP noncovalently binds p53 via its Mr 85,000 catalytic domain. Therefore, we next examined p53 as a covalent target for poly(ADP-ribosyl)ation. Although p53 was not endogenously poly(ADP-ribosyl)ated in situ, incubation of cell extracts with full-length PARP from calf thymus and [32P]ßNAD+ resulted in its time-dependent poly(ADP-ribosyl)ation. In summary, our results are consistent with the conclusion that PARP and p53 are activated with nonoverlapping kinetics during apoptosis.
1 This project was supported by Grant 9678-014 from the Texas Advanced Research Program and Grant GM45451 from the NIH.
2 To whom requests for reprints should be addressed, at Department of Molecular Biology and Immunology, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107-2699. Phone: (817) 735-2117; Fax: (817) 735-2118; E-mail: ralvarez@hsc.unt.edu.
Received 7/14/98.
Accepted 9/24/98.
This article has been cited by other articles:

|
 |

|
 |
 
T. Di Palma, T. de Cristofaro, C. D'Ambrosio, D. Del Prete, A. Scaloni, and M. Zannini
Poly(ADP-ribose) polymerase 1 binds to Pax8 and inhibits its transcriptional activity
J. Mol. Endocrinol.,
November 1, 2008;
41(5):
379 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. V. Warke, K. J. Martin, K. Giaya, S. K. Shaw, A. L. Rothman, and I. Bosch
TRAIL Is a Novel Antiviral Protein against Dengue Virus
J. Virol.,
January 1, 2008;
82(1):
555 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Alvarez-Gonzalez
Genomic Maintenance: The p53 Poly(ADP-ribosyl)ation Connection
Sci. Signal.,
December 4, 2007;
2007(415):
pe68 - pe68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Beneke and A. Burkle
Poly(ADP-ribosyl)ation in mammalian ageing
Nucleic Acids Res.,
December 3, 2007;
35(22):
7456 - 7465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Baumann, G. S. Boehden, A. Burkle, and L. Wiesmuller
Poly(ADP-RIBOSE) polymerase-1 (Parp-1) antagonizes topoisomerase I-dependent recombination stimulation by P53
Nucleic Acids Res.,
February 9, 2006;
34(3):
1036 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Beneke and A. Burkle
Poly(ADP-Ribosyl)ation, PARP, and Aging
Sci. Aging Knowl. Environ.,
December 8, 2004;
2004(49):
re9 - re9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Susse, C.-J. Scholz, A. Burkle, and L. Wiesmuller
Poly(ADP-ribose) polymerase (PARP-1) and p53 independently function in regulating double-strand break repair in primate cells
Nucleic Acids Res.,
February 2, 2004;
32(2):
669 - 680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Oliver, J.-C. Ame, S. M. Roe, V. Good, G. de Murcia, and L. H. Pearl
Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2
Nucleic Acids Res.,
January 22, 2004;
32(2):
456 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ishizuka, K. Martin, C. Booth, C. S. Potten, G. de Murcia, A. Burkle, and T. B. L. Kirkwood
Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo
Nucleic Acids Res.,
November 1, 2003;
31(21):
6198 - 6205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hasmann and I. Schemainda
FK866, a Highly Specific Noncompetitive Inhibitor of Nicotinamide Phosphoribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis
Cancer Res.,
November 1, 2003;
63(21):
7436 - 7442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wieler, J.-P. Gagne, H. Vaziri, G. G. Poirier, and S. Benchimol
Poly(ADP-ribose) Polymerase-1 Is a Positive Regulator of the p53-mediated G1 Arrest Response following Ionizing Radiation
J. Biol. Chem.,
May 23, 2003;
278(21):
18914 - 18921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Virag and C. Szabo
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Pharmacol. Rev.,
September 1, 2002;
54(3):
375 - 429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-J. Chang and R. Alvarez-Gonzalez
The Sequence-specific DNA Binding of NF-kappa B Is Reversibly Regulated by the Automodification Reaction of Poly (ADP-ribose) Polymerase 1
J. Biol. Chem.,
December 7, 2001;
276(50):
47664 - 47670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Cervellera and A. Sala
Poly(ADP-ribose) Polymerase Is a B-MYB Coactivator
J. Biol. Chem.,
March 31, 2000;
275(14):
10692 - 10696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Alvarez-Gonzalez, H. Spring, M. Muller, and A. Burkle
Selective Loss of Poly(ADP-ribose) and the 85-kDa Fragment of Poly(ADP-ribose) Polymerase in Nucleoli during Alkylation-induced Apoptosis of HeLa Cells
J. Biol. Chem.,
November 5, 1999;
274(45):
32122 - 32126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Smith and A. J. Grosovsky
PolyADP-ribose-mediated regulation of p53 complexed with topoisomerase I following ionizing radiation
Carcinogenesis,
August 1, 1999;
20(8):
1439 - 1444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guo, S. Yu, A. T. Davis, H. Wang, J. E. Green, and K. Ahmed
A Potential Role of Nuclear Matrix-associated Protein Kinase CK2 in Protection against Drug-induced Apoptosis in Cancer Cells
J. Biol. Chem.,
February 16, 2001;
276(8):
5992 - 5999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Boulares, A. J. Zoltoski, A. Yakovlev, M. Xu, and M. E. Smulson
Roles of DNA Fragmentation Factor and Poly(ADP-ribose) Polymerase in an Amplification Phase of Tumor Necrosis Factor-induced Apoptosis
J. Biol. Chem.,
October 5, 2001;
276(41):
38185 - 38192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mendoza-Alvarez and R. Alvarez-Gonzalez
Regulation of p53 Sequence-specific DNA-binding by Covalent Poly(ADP-ribosyl)ation
J. Biol. Chem.,
September 21, 2001;
276(39):
36425 - 36430.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Association for Cancer Research.